Treating OCD during COVID-19: Pharmacotherapy and combined treatments

 

Presented by Stephanie C. Eken, MD, FAAP, and Joshua Nadeau, PhD

View slides from this presentation

This presentation will provide a review of empirically supported pharmacological interventions for OCD and address some of the unique challenges of delivering this treatment both alone and in combination with CBT via telepsychiatry. 

Related resources

#
Rising above OCD from an LGBTQ+ perspective
In Angelina’s story, she discusses the identity-affirming care she received…
Learn more
#
Scrupulosity: when religious practice or matters of morality become an unhealthy obsession
“Scrupulosity is a type of OCD in which someone becomes mentally and…
Learn more
#
Live Q&A: Managing OCD in 2020
A Facebook Live discussion among Rogers' clinicians from our California…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.